Acetazolamide is a carbonic anhydrase inhibitor used to treat glaucoma, epilepsy, and altitude sickness. It decreases fluid production in the eye and alters blood pH to prevent seizures. Acetazolamide is a sulfonamide, a member of thiadiazoles and a monocarboxylic acid amide. Among its listed roles, it functions as a diuretic, an anticonvulsant and an EC 4.2.1.1 (carbonic anhydrase) inhibitor. It is the conjugate acid of acetazolamide(1-). It is derived from a hydride of a 1,3,4-thiadiazole. It is grouped under the following drug class(es): Carbonic anhydrase inhibitors, Diuretics and Sulfones. Its therapeutic use is listed as anti-epileptic drugs, anticonvulsants and ophthalmic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Nephramide, Donmox and Glaupax. Its PubChem CID is 1986.
Acetazolamide
| CAS No | 59-66-5 |
|---|---|
| Molecular Formula | C4H6N4O3S2 |
| Molecular Weight | 222.24 g/mol |
| Synonyms | N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Acetazolamide is a carbonic anhydrase inhibitor used to treat glaucoma, epilepsy, and altitude sickness. It decreases fluid production in the eye and alters blood pH to prevent seizures.
The listed CAS number is 59-66-5.
The listed molecular formula is C4H6N4O3S2.
The listed molecular weight is 222.24 g/mol.
N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide.
The source lists Nephramide, Donmox and Glaupax.